Financing ·
The Oncology Institute, Inc. entered into a $75 million term loan agreement with Orbimed Opportunities (CA) V LLC…
DFPHStarling Oncology, Inc.
The Oncology Institute, Inc. entered into a $75 million term loan agreement with Orbimed Opportunities (CA) V LLC, which was drawn in full on July 1, 2026. The company used the proceeds to fully repay $86 million in 4% senior secured convertible notes due 2027. Additionally, the company issued 10,025,535 warrants to Deerfield Partners, L.P. to purchase common stock at an exercise price of $8.567 per share. The Oncology Institute, Inc. operates in the healthcare sector, providing oncology-related medical services.